John Noh Selected Research

Cysticercosis

8/2023	Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study.
5/2022	Prevalence of Epilepsy, Human Cysticercosis, and Porcine Cysticercosis in Western Kenya.
4/2022	Seroprevalence and Associated Risk Factors of Trichinellosis and T. Solium Cysticercosis in Indigenous Pigs in Hoa Binh Province, Vietnam.
11/2021	Evaluation of an Antibody Detecting Point of Care Test for Diagnosis of Taenia solium Cysticercosis in a Zambian Rural Community: A Prospective Diagnostic Accuracy Study.
12/2019	Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam, Tanzania.
4/2010	Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans.
1/2010	Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis.
6/2003	Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Noh Research Topics

Disease

8	Neurocysticercosis 08/2023 - 01/2010
8	Cysticercosis 08/2023 - 06/2003
3	Cysts 01/2018 - 01/2010
2	Parasitic Diseases (Parasitic Disease) 05/2017 - 06/2003
2	Taeniasis 04/2010 - 01/2010
1	Myelitis 01/2020
1	Encephalomyelitis (Myeloencephalitis) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Seizures (Absence Seizure) 05/2013
1	Epilepsy (Aura) 05/2013

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 08/2023 - 06/2003
5	lentil lectinIBA 01/2018 - 06/2003
5	EnzymesIBA 01/2018 - 06/2003
5	Glycoproteins (Glycoprotein)IBA 01/2018 - 06/2003
4	AntibodiesIBA 11/2021 - 04/2010
2	Indicators and Reagents (Reagents)IBA 11/2021 - 05/2013
2	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2010
2	Recombinant ProteinsIBA 05/2014 - 04/2010
1	4-hexyloxyaniline (HOA)IBA 04/2022
1	Peptides (Polypeptides)IBA 05/2014
1	ImmunosorbentsIBA 06/2003

Therapy/Procedure

1	Therapeutics 01/2016